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INTRODUCTION 15
Responding to viral pandemics or to the emergence of new microbial pathogens is a major 16 challenge to public health 1 . A critical component to this response is the prediction of the course 17 of microbial evolution. One approach to this prediction uses available genomic samples and 18 branching patterns of genealogical trees to statistically project future dominant strains 2 . 19
However, this approach can only infer the likelihood that an existing viral strain will dominate, 20 and cannot predict emergence of novel strains that might become dominant due to de novo 21 beneficial mutations. It is these novel strains that are often the most virulent, posing the greatest 22 hazard to public health. Predicting the evolution of novel strains is the key to addressing this 23 challenge and requires knowledge of the relationship between mutations in the viral genome and 24 the fitness for individual organisms 3 . This relationship is the fitness landscape, which is a 25 complex, multidimensional function; however, this can rarely be quantitatively determined. 26
Nevertheless, it is essential for predicting selection of the most probable mutants. Moreover, the 27 fate of mutations is also a function of population structure 4 . In particular, population size 28 changes the balance between the impact of random mutations on fitness and that of selection 5 29 and is thought to affect both the rate and direction of evolution 6 . Recent studies use microbial 1 fitness landscapes 7-9 or population structure 10,11 to predict the course of evolution, but to date, 2 none links these elements together. Without this link, further progress in predicting the course of 3 viral evolution is significantly hindered. 4
In this paper, we quantitatively determine a fitness landscape for an RNA virus subjected to the 5 environmental pressure of a neutralizing antibody, and use it to account for the evolution of the 6 virus under conditions that constrain population size. The experimentally measured fitness 7 landscape is correctly described by two biophysical parameters: the thermodynamics of folding 8 of the capsid protein and its binding to the antibody. We probe the evolution of a model 9 norovirus both in bulk, where population size is large, and in a microfluidic evolution chip which 10 uses small drops to perform millions of experiments 12-16 that probe evolution in very small 11 population sizes. We show that the dynamics of viral adaptation is strongly dependent on 12 population size. These results can be quantitatively described by a theoretical framework that 13 combines protein biophysics and population genetics, providing the critical link between fitness 14 landscape and population structure that enables prediction of evolution. 15 We focus in this work on Murine Norovirus (MNV), a model for human RNA viruses which are 16 the major cause of epidemics in the world [17] [18] [19] . MNV is a non-enveloped RNA virus that consists 17 of 180 copies of the capsid protein assembled around a 7.5kb long positive-strand RNA genome. 18
It mutates at ~1 base per genome per replication cycle and produces ~10 4 progenies in a single 19 cell infection, of which ~100 are infectious viral particles, or plaque forming units (pfu) 12 . 20
RESULTS 21

Lab evolution of Norovirus in large and small population sizes 22
To study viral evolution, we propagate a viral isolate (MNV-1, denoted wt) in the presence of a 23 neutralizing antibody (mAb6.2, 20 ) that binds to the protruding domain (P-domain) of the capsid, 24 and prevents virus entry into the host cell 21, 22 . This set-up allows us to study the way the virus 25 evolves to adapt to a new environment. To investigate the dynamics of this escape from the 26 antibody, we sequence a 376 bp fragment of the genome encoding the outermost part of the P-27 domain (residues 281 -412 of VP1) and follow the frequency of 37,244 unique haplotypes 28 (Figure 1-figure supplement 1 and Table S1 ) observed over several passages, allowing us to 1 follow the evolution over several generations. First, we propagate wt in standard bulk culture 2 conditions, using ~10 6 virions per passage under Ab pressure (Figure 1A) . The population is 3 initially dominated by the wt (~90% of the population) with the rest of the viral quasi-species 4 consisting of single and double mutants (Table S1). After 2 passages the total number of 5 surviving viruses has decreased significantly due to the neutralizing effect of the Ab 6 ( Figure 1-figure supplement 2) ; however, three single mutants E296K (A), D385G (B), T301I 7 (C) as well as their double mutants (AB, AC, BC) occur at higher frequencies than the other 8 haplotypes. By the fourth passage the triple mutant ABC, which first arises on passage 2, occurs 9 at a frequency even higher than the other mutant haplotypes (86%); moreover, the total number 10 of viruses increases to levels comparable to those observed after the first passage 11 (Figure 1-figure supplement 2) . This suggests that ABC is an escape variant. 12
A central tenet of evolutionary theory is that the way organisms explore their fitness landscape 13 depends on the size of their population, which controls the balance between random mutational 14 drift (i.e., direction of randomly arising mutations) in the population and fitness driven selection 15 (i.e., direction of beneficial mutations) 4,5 . This balance determines the most likely evolutionary 16 pathways on a given fitness landscape. Indeed, the population size may be particularly important 17 for noroviruses where a single viral particle is sufficient to infect the host animal 23 ; thus it is 18 possible that viruses propagate in very small populations as they adapt to a new environment 19 prior to the emergence of an epidemic. 20
The consequences of a smaller population size are captured by the S. Wright's shifting balance 21 theory 6 , which hypothesizes that evolution can proceed more efficiently in three phases: i) a 22 population is divided into subpopulations to weaken selection and increase drift, ii) each 23 subpopulation evolves independently, whereupon iii) the subpopulations are mixed back into a 24 large population and then all individuals compete. We can directly probe this hypothesis 25 experimentally by drastically reducing population size compared to typical laboratory bulk 26 cultures, which propagate ~10 6 to 10 8 viruses (Figure 1-figure supplement 2) . To evolve 27 viruses in small population sizes we use a novel microfluidics system, the "Evolution Chip", 28 which propagates ~10 6 subpopulations of 1-10 infectious particles (pfu) in distinct and non-29 mixing compartments (Figure 1B, Figure 1-figure supplement 3 , Movie S1 and Movie S2). 30
The microfluidics system allows us to drastically reduce the population size without reducing the 1 total number of viruses sampled, thereby maintaining the statistics comparable to that of a bulk 2 experiment. 3
Figure 1. Wright's shifting balance theory (SBT) -Viral evolution in large and small population sizes.
A) Top: 10 6 viruses evolving against a neutralizing antibody in bulk by serial propagation. Bottom: The allele frequencies of 1,364 distinct P-domain haplotype sequences are plotted per passage (see also Figure S2 ). B) Viral evolution in small populations. Top: Experimental scheme of the three phases of Wright's SBT -Phase 1: 10 6 pico-liter drops are loaded with on average 1 virus and 2 host cells per drop. Phase 2: viruses evolve in drops for five passages. Phase 3: the emulsion is broken and all lineages evolve together in bulk for 3 additional passages (frequencies for passages 6 and 7 are interpolated from passages 5 and 8, see also Figure S3 and Movie S1, S2). Bottom: The allele frequencies of 620 distinct P-domain haplotypes from B (Phase 2, center panel, phase 3 right panel) are plotted per passage. ( Figure S2 ). C) Exploration of the fitness landscape for the three phases of SBT -phase 1 (left): a previously adapted population (lower peak on left fitness landscape) is partitioned into smaller subpopulations. phase 2 (middle): small sub-populations adapt in isolated conditions where selection pressure is reduced, allowing an extended exploration of the fitness landscape. phase 3 (right): subpopulations migrate, mix and compete, evolving new and more fit variants that were explored in isolation (highest peak). Haplotype legend: A: E296K, B: D385G, C: T301I, D: A382V.
The following supplements are available for Figure 1 : 25 Table S1 . Complete list of MNV-1 variants from deep sequencing 26 Movie S1. Encapsulation of virus and cells in drops 27 Movie S2. "Evolution Chip" for serial passaging in drops
28
In stark contrast with the bulk experiments, amplification and hence growth of potential escape 1 variants that sweep the population is precluded when each variant is confined in a single drop 2 with just two host cells; as a result, the wt remains the dominant fraction of the observed viruses 3 through all passages. Potential escape viruses are present, but are in complete isolation from each 4 other, at population sizes of just a single infection event per generation. This microfluidic 5 experiment ( Figure 1B) implements the first two phases of the shifting balance theory 6 : i) 6 partitioning the population in drops to weaken selection and increase genetic drift and ii) 7 evolving the sub-populations without competition between drops. However, the absence of 8 competition precludes detection of potential escape variants. To overcome this, we break the 9 emulsion after five passages in the evolution chip, mix the contents of all the drops and 10 propagate the sample in the presence of Ab under bulk conditions for three additional passages 11 26 . This enables new escape variants that evolved in isolation to take over the integrated 12 population and facilitates their identification, isolation and characterization. This also 13 implements the third phase of the shifting balance theory: iii) mixing the subpopulations back 14 into a large population. Remarkably, after mixing, a double mutant, D385G-A382V (BD), 15 sweeps the population; ( Figure 1B) this is in sharp contrast with the standard bulk cultures 16
where the triple mutant ABC sweeps the population. 17
Next, we determine if the escapees in drops are more fit than the escapees in bulk. To address 18 this question, we engineered the mutations into the infectious clone and recovered mutant 19 viruses. Next, we performed head-to-head competition of wt, BD, and ABC variants. We show in 20 Figure 2 the frequency of each of the three clones at the end of the competition. Indeed, BD and 21 ABC are true escape variants since they outcompete wt under neutralizing antibody. However, 22 without antibody, wt is more fit than both BD and ABC, which explains the observation that 23 neither BD nor ABC spontaneously arise in serial passaging without Ab. More importantly, in the 24 competition between BD and ABC, we find that the escapee from droplets is more fit compared 25 to the escapee from bulk ( Figure 2 ). Despite being more fit, BD is not detected in any of the bulk 26 serial passaging under neutralizing Ab, while ABC was observed thrice. We hypothesize that the 27 initial acquisition of the mutation D (enroute to BD) is limited in large populations, because 28 epistatic interactions dictate that the virus traverse a low fitness regime, before climbing up a 29 local fitness peak. Indeed, such unlikely pathways on the landscape can be accessed if selection 30 is weakened by decreasing population size as Wright originally envisioned. 31 Table S2 .
The following supplement is available for Figure 2 : Table S2 . Analysis for head to head competitions
Fitness landscape of norovirus escaping an antibody is projected onto the biophysical properties of its capsid domain
These results provide strong qualitative support to Wright's shifting balance theory showing that 1 the evolutionary dynamics and outcome dramatically depend on the population structure. To 2 understand these dynamics quantitatively we must first develop a tractable model for the fitness 3 landscape of the virus. In general, fitness is expected to be a complex function of multiple traits. 4
Instead we focus on the dependence of viral fitness in the presence of a neutralizing antibody on 5 two biophysical properties of the P-domain: The folding energy, which is a measure of stability, 6 and the binding affinity to the antibody, which is a measure of neutralization. While the 7 importance of binding affinity to antibody is apparent, the universal importance of protein 8 folding stability for bacterial and viral fitness was also shown 8,27 . This choice of variables is 9 further supported by the fact that all the mutations of the dominant escape variants we observe in 10 our experiments are located within the binding site between the P-domain and the Ab, as shown 1 by mapping the mutations on the 3D structure of the wt P-domain in Figure 3A . 2
Figure 3. Fitness landscape of norovirus escaping a neutralizing antibody
A) The P-domain Antibody complex structure. The SNPs of all dominant P-domain variants (red circles) are located on the docking site of the P-domain-antibody complex (PDB ID: 3LQE). B) A high correlation exists between Ab dissociation constant K d that was experimentally measured using surface plasmon resonance (SPR) and the one computed from force field calculations C) The anti-correlation between the experimentally measured P-Domain melting temperature (T m ) and the folding stability computed from force field calculations. Two outlier variants were excluded from the analysis. D) A 3D plot of the probability of infection F averaged over 2,076 distinct haplotypes binned according to their dissociation constant K d and folding stability ∆G fold (blue points) overlaid with the theoretical fit according to Eq. 1 (gray surface). Cross sections (black frames) demark the regions used for the projections in B and C. E) The probability of infection for all haplotypes with ∆G fold <4.5Kcal/mol (cross section parallel to K d axis in A) is projected on the K d -F plane, binned according to their K d (blue points) and overlaid with the theoretical fit to Eq. 1 (dashed line). F) The probability of infection for all haplotypes with K d >10 3 nM (cross section parallel to ∆G fold axis in A is projected on the ∆G fold -F plane, binned according to their ∆G fold (blue points) and overlaid with the theoretical fit to Eq. 1 (dashed line). F is determined from deep sequencing lysates of in vitro experiments in the presence of neutralizing antibody. K d and ∆G fold are estimated from mapping the haplotype mutations to the 3D structure of the capsid P-domain in complex with the neutralizing antibody.
The following figure supplements are available for Figure 3 : 
19
To calculate the folding energy of the P-domain and its binding affinity to the antibody for each 20 haplotype sequence, we use force field calculations based on the structural mapping in 21 26, 28 to determine the change in folding energy ∆∆G fold between the mutant and the wt; 22 from this we determine ∆G fold of the mutant by adding the folding energy of the wt, ∆G wt . We 23 also determine the change in binding energy, ∆∆G bind , between the mutated P-domain-Ab 24 complex and the wt; from this we determine the dissociation constant
where K 0 is the dissociation constant of the wt. We test the accuracy of our calculations by 26 comparing the calculated biophysical properties of the escape haplotypes to experimentally 27 measured properties. To accomplish this, we express and purify the P-domain of each 1 haplotype 29 and measure its binding to the Ab to extract K d ; we also measure the melting 2 temperature of the P-domain, T m , which correlates inversely to ∆G fold (Table S3 and The biophysical fitness landscape describes the dependence of viral fitness in the presence of a 1 neutralizing antibody on ∆G fold and 1/(mK d ), where the parameter m accounts for the multiple 2 binding sites of the capsid. To formulate the viral fitness we assume that the wt P-domain occurs 3 in three specific states: folded and unbound, folded and bound, and unfolded (which is always 4 unbound). The virus infects only when the P-domain is folded and unbound, hence, we can 5 express the viral infectivity F at a given concentration of antibody [Ab] as 31 : 6
,
where the numerator is the Boltzmann probability of being folded and unbound and the 8 denominator is the partition function that sums over the probability of all three states, and 9 β=1/k B T where k B is the Boltzmann constant and T is the temperature. The function F has two 10 regimes as shown by the surface in Figure 3D . For low binding affinities and stable P-domain 11 structures, viruses are expected to infect host cells at some fixed probability, 0<b 0 <1, 12 determined by the average effect of all remaining viral properties on the infection process, and 13 F=b 0 . By contrast, when the binding to the Ab is strong or when the P-domain is unstable, the 14 virus cannot infect its host and F=0. 15 To compare the model to experiment, we use sequencing data to determine the growth rate of 16 each virus from the change in genome haplotype frequencies between successive generations 9 . 17
The growth rates distribute into two distinct groups with 87% of haplotypes exhibiting little or 18 no growth and the rest exhibiting considerably larger growth. We take the first group to be non-19 infective, and take the second group to be infective (Figure 3-figure supplement 1A) . For each 20 haplotype sequence, we map the mutations to the 3D structure of the wt P-domain 28 and use Eris 21 force field calculations to determine the change in folding energy ∆∆G fold between the mutant 22 and the wt; from this we determine stability of the mutant ∆G fold =∆G fold,wt +∆∆G fold , where ∆G wt is 23 the folding energy of the wt. We also determine the change in binding energy, ∆∆G bind , between 24 the mutated P-domain-Ab complex and the wt; from this we determine the dissociation constant 25 K d =K 0 e β∆∆G bind where K 0 is the dissociation constant of the wt. We bin the haplotypes using 26 The value of 1/m≈1.4% obtained from the fit reflects the fact that only about 3 of the 180 P-7 domains on the capsid have to be blocked by the Ab to prevent infection (Figure 3E and ref. 12 ). 8
The value of F ~0.25 at the plateau is significantly less than the expected value of b 0 =1; this 9 points to the role of factors not included in the model, such as the interaction of the capsid with 10 the host-cell receptor, in successful infection. In the absence of the neutralizing antibody, we do 11 not expect the fitness landscape to depend on K d , which is indeed the case (Figure 3-figure  12 supplement 2). Altogether, these results demonstrate that binding and folding energies are very 13 good predictors of viral extinction; however they are less successful in predicting infectivity. 14 This suggests that antibody escape and folding stability of the capsid protein are necessary but 15 not sufficient for viral infection. 16
Most likely pathways on the fitness landscape predicted by protein biophysics and 17 population genetics 18
To determine how the virus evolves on the fitness landscape, we use population genetics theory 19 and calculate the ratio dN/dS, where dN is the rate of non-synonymous evolutionary rate and dS 20 is the synonymous evolutionary rate 32 (For greater details, see section on Balance between 21 selection and mutational drift on the fitness landscape in the Materials and Methods). As a rule, 22 mutants affect the population more in regions where non-synonymous mutations are beneficial 23 (high dN/dS), driving it down the gradient of dN/dS towards regions where non-synonymous 24 mutations are deleterious (low dN/dS) and thus do not affect the population. The dN/dS ratio is a 25 function of population size and of the fitness effect of a mutation or the selection coefficient 26 s=(F mutant -F widltype )/ F widltype 32,33 . Using the fitness landscape from Equation 1, we calculate the 27 dN/dS ratio on the viral fitness landscape and how it depends on population size (see Methods 28 and 34,35 for details). In large population sizes, dN/dS exhibits a strong gradient towards high K d 1 and high folding stability ( Figure 5A) . Consequently, a wt population that is initially unstable 2 and neutralized by Ab is expected to evolve resistance by increasing both K d and stability. 3 However, in small population sizes the gradient of dN/dS is directed only towards high K d and 4 the same initially unstable population will evolve resistance to Ab without increasing folding 5 stability (Figure 5B) . 6
The effect of population size on the course of evolution can be explained by analyzing the 7 balance between selection and mutational drift, the two forces driving evolution. The direction of 8 drift and selection along the trait of folding stability and binding affinity to the antibody can be 9 inferred from protein engineering and systematic studies on effects of random mutations on 10 proteins. Along the axis of folding stability ΔG fold , beneficial mutations increase folding stability, 11 but random de novo mutations in proteins tend to decrease stability [36] [37] [38] [39] . Thus, selection and drift 12 act in opposite directions (Figure 5A-B, arrows) , leading to mutation-selection balance. Along 13 the axis of binding affinity K d , beneficial mutations for the virus lead to escape from Ab (towards 14 high K d ), and random mutations on protein interfaces perturb binding (also towards high K d ). 15
Thus, selection and drift act along the same direction (Figure 5A-B, arrows) . 16
To validate the difference in expected pathways to antibody resistance based on population size, 17 we simulate the trajectory for 4 sequential fixations of a single mutation starting from the 18 position of the wt virus population on the viral fitness landscape (see 31 for details). For large N, 19 the simulations show that the norovirus population increases both its folding stability and 20 dissociation constant, K d , as it escapes the neutralizing antibody, following the trajectory shown 21 by the solid points in Figure 5A . For large population sizes, the increase in K d is strongly coupled to the increase in T m . However, for small population sizes, the selection for K d is decoupled from the selection for folding stability. The white lines are the predicted trajectories from forward evolutionary simulations of an MNV population escaping an Ab, but with a P-domain which is unstable. Each trajectory is the average of 1000 independent simulations. The direction of selection (black arrows) is towards greater folding stability and weaker affinity to the antibody. Selection is strong when the P-domain is unstable and/or is tightly bound to the Ab. Selection pressure is approximately zero when the fitness landscape is flat (neutral). Along the direction of folding stability, most random mutations are destabilizing which lead to a mutational drift (white arrows) towards protein destabilization. Along binding affinity axis, most random mutations perturb the protein-protein interaction that leads to a mutational drift towards weaker binding. C,D) Density plots of all haplotypes grouped according to passages. Color circles denote dominant haplotypes whose biophysical properties were measured, while the remaining gray circles denote haplotypes whose biophysical properties were calculated. The size of the circle represents the allele frequency of each haplotype. Gray cross at passage 5 denotes mean and s.d. of all haplotypes.
The following figure supplement is available for Figure 5 : The average folding stability and K d is shown for 5 simulated passages of populations of 10 and 3 10 6 viruses. The simulation was repeated once for the large population and 1,000 times for the 4 small population and the average of all repeats are shown (SSE error bars are not visible 5 at<0.1%). For this simulation we used the initial conditions: ∆G fold =-2.5kcal/mol, K d =46 nM,
6
[Ab]=8 nM and µ r =0.1.
8
To compare the theory to experiment we plot the position of viral haplotypes evolving in 9 5 independent bulk passaging experiments as a function of K d and T m , denoting their frequencies 10 by the size of the circles for each passage. To that end we include the calculated biophysical 11 values K d and T m (gray haplotypes), using the correlation curve in Figure 3B to relate between 12 ∆G fold and T m , as well as the biophysically measured values for select haplotypes (colored 13 symbols). There is a clear trajectory as the intermediate variants evolve, having increasingly 14 weaker affinities and higher T m , with the escape variants at passage 5 ultimately having the 15 weakest affinity, with an overall average of K d ~3,000 nM and the highest P-domain stability 16
with an average of T m~4 3.5°C, as shown in Figure 5C . We also plot the position of viral 17 haplotypes evolving in ~2 million independent drop passaging experiments. We observe a clear 18 trajectory of increasingly weaker affinities while maintaining original T m , with the escape 19 variants at passage 5 ultimately having an overall average of K d ~300 nM and T m~3 6.8°C, as 20 shown in Figure 5D . The direction of these trajectories parallels that of the simulated 21 trajectories, supporting our choice of these explicit biophysical properties as valid and useful 22 coordinates for the fitness landscape. This also provides us a theoretical framework with which 23 to interpret new experimental data and to test fundamental concepts of evolutionary theory. 24
DISCUSSION 25
It is a central concept in evolutionary biology theory that the population size determines the 26 balance between two evolutionary forces, selection and mutational drift 5,34 . The results 27 presented here provide direct experimental evidence in support of this central concept. Moreover, 28 the role of Wright's shifting balance theory in real evolution has been contentious and 29 controversial because of lack of direct experimental demonstration 40 . Using the segregation in 30 the Evolution Chip, we show that isolated viral populations starting at a fitness valley in the 1 presence of a neutralizing Ab are able to explore unlikely pathways on the adaptive fitness 2 landscape and, following migration, shift the whole population to new fitness peaks ( Figure 1C) ; 3 this is a direct demonstration of the shifting balance theory. 4
The ability to change the course of evolution using the Evolution Chip and to predict its direction 5 on the biophysical fitness landscape with the parameters of protein stability and binding may be 6 helpful in addressing pandemics. These biophysical parameters are more generally applicable to 7 other viruses; for example, both binding 41 and folding stability 8 are relevant traits for the 8 evolution of an influenza virus in the presence of a neutralizing antibody. Prediction of future 9 diversification of circulating viral mutants is key to developing and potentially fielding an 10 effective vaccine prior to, or in the early stages of a pandemic. The methodology presented here 11 may assist in proactive exploration of viral diversification to inform selection of novel viruses 12 prior to their natural emergence, for developing viral therapeutics. 13
14
MATERIALS AND METHODS 15 16
Microfluidic devices: 17
We fabricate polydimethylsiloxane (PDMS) devices using photolithography and coat them with 18 fluorophilic Aquapel (Rider, MA, USA) to prevent wetting of drops on the channel walls. 19
Electrodes are fabricated on chip using low melting temperature solder 42 . The designs used to 20 fabricate the devices are available in ACAD format (Supplementary File S1). We use OEM 21 syringe pumps (KD Scientific, MA, USA) to drive the fluidics and a fast camera (HiSpec1,  22 Fastec Imaging,USA) to image encapsulation and drop fusion. E296K-T301I-D385G (ABC) were generated as previously described 20 . The isotype control IgG 6 directed against Coxsackievirus B4 (CV) (clone 204-4) was purchased from ATCC (HB 185). 7
Anti-MNV-1 monoclonal antibody (mAb) A6.2 (IgG2a) was grown in Bioreactor CELLine CL 8 1000 flasks (Sigma-Aldrich) following the manufacturer's recommendations. Antibodies were 9 purified over a HiTrap protein A column (GE Healthcare) according to the manufacturer's 10 instruction, dialyzed against PBS, and stored at -20 °C. 11
12
MNV-1 P-domain mutant expression and purification 13
All recombinant proteins was expressed and purified as previously reported 21 with some 14 modifications. Briefly, the P domain of MNV-1 (residues 225 to 541) was cloned into a pUC57 15 expression vector with NH2-terminal 6-histidine tag. The protein was expressed overnight at 16
20°C in Escherichia coli. The cells were subsequently lysed, and the protein was obtained from 17 the supernatant, two steps purification by Ni column and by gel filtration on a Superdex 75 18 column (GE Healthcare). The proteins were dialyzed overnight at 4°C against a phosphate buffer 19 (pH=7.8 and 20 mM NaCl). 20 21 Folding stability measurement by thermofluorescence 22
Thermal denaturation was carried out using melt-curve module of BioRad CFX96, and Sypro 23
Orange dye as a probe for unfolding as described earlier 45 RAW 264.7 suspension cells are centrifuged for 5 min at 3,000 rpm and re-suspended in fresh 25 medium at a concentration of 6x10 6 cells/mL. In antibody neutralization experiments, virus is 26 first incubated for 30 min at 37°C with mAb A6.2 in 200 µL PBS prior to dilution into ESM at 27 4x10 6 pfu/mL, such that the final Ab concentration is 8.57 nM. One mL of cell suspension and 1 28 mL of virus suspension are mixed in a single well of a 12-well dish containing a sterile stir bar 29 and incubated on stir plate in a 37°C incubator, 5% CO2, for 24 hrs. To passage viral progeny to 30 the next generation (the progeny of the first inoculum is considered passage 0 (P0)), 250 uL of 31 the supernatant from cell lysates of the previous generation is supplemented to 2 mL of a fresh 32 suspension of 2x10 6 RAW cells/mL in ESM in a 12-well dish containing a sterile stir bar and 33 incubated on the stir plate in a 37°C incubator, 5% CO2, for 24 hrs. In antibody neutralization 34 experiments, 8.57 nM mAb A6.2 is supplemented to the fresh suspension of RAW cells prior to 35 passaging. Cell lysates were harvested by 2 rounds of freeze/thaw and centrifugation for 5 min at 1 5,000 x g. 2 3 Viral evolution in drops 4
To evolve viruses in small population sizes we use a novel microfluidics system, the "Evolution 5
Chip", which propagates ~10 6 subpopulations of 1-10 infectious particles (pfu) in distinct and 6 non-mixing compartments. We encapsulate ~2 host cells and ~1 pfu in 100µm diameter aqueous 7 drops in inert oil at a rate of millions per hour. The resultant emulsion is incubated under 8 physiological conditions for one viral life cycle (~24 hours). Successful replication of the virus 9
leads to the death of the host cell and the release of viral progeny within the drop. Thus, to 10 enable continued passage, each drop is split and ~10% of its volume, containing viral progeny 11 from the previous generation, is merged with a new drop containing a fresh host cell for the next 12 generation. 13
Suspension-adapted RAW 264.7 cells were centrifuged for 5 min at 3,000 rpm, re-suspended in 14 ESM at 8x10 6 cells/mL. The suspension of cells is co-flowed at a 1:1 ratio with MNV-1 virus 15
diluted into ESM at 4x10 6 pfu/mL. The two aqueous phases -cell suspension and buffer -meet 16
immediately before passing through the microfluidic drop making junction so that they only mix 17 inside the 100um drops containing them (Supplementary Movie 1) . For the continuous phase 18
dispersing the drops, we use HFE-7500 Oil with 1% surfactant. Typical flow rates are 8 mL/hr 19 for the oil and 2 mL/hr for cells and virus. Drops were collected in 1.5 mL tubes and incubated at 20 37°C, in 5% CO 2 . Following 18-24 hr incubation at 37°C, drops are re-injected into the 21 "evolution-chip" microfluidic device where ~10% of their volume is split off and fused with 22 freshly formed drops containing freshly prepared suspension of RAW cells in ESM. The 23 synchronization in the device ensures that in >95% of cases, the split from one drop fuses 24 with exactly one newly formed drop, enabling the viral lineages to propagate in isolation. 25
Typical flow rates are 4 mL/hr for the oil, 1 mL/hr for the re-injected drops, and 1 mL/hr for the 26 fresh cells. The newly formed drops are collected in 1.5 mL tubes and incubated at 37°C, in 5% 27 CO 2 , while the content of the old, split drops are extracted for analysis (The progeny of the first 28 encapsulation is considered passage 0 (P0)). In antibody neutralization experiments, 8.57 nM 29 mAb A6.2 is supplemented to the fresh suspension of RAW cells prior to re-injection of drops. 30 31 Head to head competitions between viral strains 32
Next, we determine if the escapees in drops are more fit than the escapees in bulk. To address 33 this question, we performed head-to-head competition of wt, BD, and ABC strains. We mixed 34 equal viral titers of each pair of strains, passaged them for 3 rounds and then performed deep 35 sequencing. The competition was performed under two conditions, with and without neutralizing 1 antibody, and over three replicates. The sequencing results of the competitions are given in 2  Table S2 . 3 RAW 264.7 suspension cells are centrifuged for 5 min at 3,000 rpm and 2 mL of a fresh 4 suspensions of 1x10 6 RAW cells/mL in RAW medium is dispensed in 6-well plates. In antibody 5 neutralization experiments, virus is first incubated for 30 min at 37°C with mAb A6.2 in 200 µL 6 PBS prior to adding it into the wells, such that the final Ab concentration is 0.08 nM. Cells and 7
virus are incubated in a 37°C incubator, 5% CO 2 , for 48 hrs. To passage viral progeny to the next 8 generation (the progeny of the first inoculum is considered passage 0 (P0)), 200 uL of the 9 supernatant from cell lysates of the previous generation is supplemented to 2 mL of a fresh 10 suspension of 1x10 6 RAW cells/mL in RAW medium in a 6-well dish and incubated in a 37°C 11 incubator, 5% CO 2 , for 24 hrs. In antibody neutralization experiments, 0.08 nM mAb A6.2 is 12
supplemented to the fresh suspension of RAW cells prior to passaging. Cell lysates were 13
harvested by 2 rounds of freeze/thaw and centrifugation for 5 min at 5000 x g. 14
In-vitro neutralization measurements 15
To measure neutralization in-vitro we followed Fischer et. al 12 to obtain a neutralization curve 16 which we then fit by the equation
where y is the viral titer, X is the Ab 17 concentration and k d is the fitting parameter. 18
In-vivo neutralization measurements 19
Mouse studies were performed in accordance with local and federal guidelines as outlined in the 20 "Guide for the Care and Use of Laboratory Animals" of the National Institutes of Health. 21
Protocols were approved by the University of Michigan Committee on Use and Care of Animals 22 (UCUCA Number: 09710). Viral strains were neutralized in STAT -/mice injected with 500ug 23 mAb A6.2 and compared to their infection in mice injected with an isotype as described in 48 . 24
The decrease in viral titers was first standardized for each tissue across viral strains, before the 25 average over all tissues within each strain was taken as its final neutralization score. The study 26 was performed in biological triplicates. No randomization or blinding was used. 27 28
Measurement of infectious virus titer 29
Viral titer was determined by either plaque assay, as described previously 49 , or by TCID50 assay, 30
as described previously 50 . TCID 50% infectivity was translated to plaque forming unit (pfu) 31
using the conversion of 0.7 TCID50 units to 1 pfu. 32
Quantification of viral genome 1 Viral RNA isolated from experimental samples by MagMAX Viral RNA Isolation Kit (Life 2 Technologies) was evaluated by qPCR using MNV-1-specific primer/probe sequences (Forward: 3 GTGCGCAACACAGAGAAACG, Reverse: CGGGCTGAGCTTCCTGC, and probe: 4 FAM/CTAGTGTCTCCTTTGGAGCACCTA/TAMARA) 21 . Takara One Step reagent 5 (Mountain View, CA) was used to measure the genome copy of viral samples. qRT-PCR was 6 performed on ABI real time PCR machine (OneStep Plus) using the following thermal cycling 7 parameters: 5 min at 42° C and 10 sec at 95° C, 40 cycles of 5 sec at 95° C and 34 sec at 60° C. 8
Titered MNV-1 viral stock and PicoGreen (quBit)-quantitated pT7 MNV 3'RZ plasmid 50 were 9 used as standards for pfu/mL and genome copies/mL analysis, respectively. 10 11 Amplicon preparation and sequencing 12 Viral RNA was isolated using the MagMax viral RNA kit (Life Technologies), then subjected to 13
DNAse digest using DNAfree Turbo DNAse (Life Technologies). SuperScript III reverse 14 transcriptase (Life Technologies) was then used to convert vRNA to first strand DNA with 15 specific primers tiling the entirety of MNV-1 at ~1kb increments using the following primers: 16 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGGGAGAAAGGGACCAATT; 31 gene specific portion in bold). After purification with Ampure XP (Beckman Genomics), 1 samples were quantified using Qubit high sensitivity reagents (Life Technologies), then pooled 2 in equimolar ratios assuming specific amplification during adapter addition. Final pools of up to 3 96 libraries were quantified using high sensitivity Bioanalyzer reagents (Agilent) prior to 4 sequencing 2X250 bp long paired end reads of the amplicons with miSeq (v2 chemistry, miSeq 5 control software v2.3.0.3). Samples were supplemented with 10% phiX control library 6 (Illumina). All reagents were used according to manufacturer's recommendations, and obtained 7 from Life Technologies unless otherwise noted. 8 9 Amplicon sequencing analysis 10 Paired end reads were obtained from the MiSeq after going through the MiSeq Reporter 11
Generate FASTQ Workflow, which demultiplexes the raw data by MID pair (removing adapter 12 sequences in the process), and creates a separate pair of output files for each paired-end sample. 13
These paired-end reads are aligned to the MNV-1 reference sequence (RefSeq: NC_008311) 14 using bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/) and only reads that include the 15 amplicon range (nucleotides 5918 to 6293 of MNV-1) without insertions and deletions are 16
analyzed. SNPs in each of the remaining reads are saved for further analysis together with their 17
Illumina reported quality. SNPs in overlapping regions of the paired end reads are called using 18 the read with the higher quality. If the call in both forward and reverse reads match, the quality 19 of SNP is taken as the sum of qualities, otherwise, the difference between the higher and lower 20 quality is taken. Sequences with more than 20 substitutions were discarded and the remaining 21 reads were then clustered into unique candidate haplotypes and tested for statistical significance 22
using a hypothesis test. The null hypothesis presumed that a haplotype candidate is generated by 23 sequencing errors in the reading of one of its "potential ancestors". Potential ancestors are 24 haplotypes that are both "nearest neighbors" -have the smallest hamming distance to the 25 candidate -and are more frequent -have more reads than the candidate. We used a simple 26 generative model using a base-calling substitution rate equal to the lowest read quality recorded 27 for any of the relevant substitutions in the candidate reads and then calculated the probability that 28 the observed candidate was derived from this distribution (see next section on Determination of 29 Significance). 30
Determination of significance from sequencing 31
Initially, the most abundant haplotype is assigned P-value=0. Haplotypes are tested in 32 descending order of their frequency. For each haplotype, a group of "potential ancestor 33
haplotypes" was defined as those haplotypes that are both "nearest neighbors" -have the smallest 34 hamming distance to it -and are more frequent -have more reads than this haplotype. The single 35 event probability that a copy of the candidate haplotype was generated while sequencing a copy 36 of each potential ancestor is calculated using the quality of reads of the nucleotides that differ 37 between the two haplotypes: the score for each substitution address was calculated as the lowest 1 quality over all reads sequenced in that address for the candidate haplotype. The final score was 2 calculated from the product of all single substitution scores. The probability P ij that a candidate 3 haplotype i was generated by sequencing errors in the reading of a potential ancestor j was 4 determined using the complementary cumulative density (CCDF) of a binomial function, with 5 the number of trials equal to the frequency of the potential ancestor, the number of successes 6 equal to the frequency of the candidate haplotype and the success rate taken as the single event 7
probability. This probability is calibrated according to the probability of ancestor P j so that 8 P ij
Finally, the P-value of haplotype i is calculated as the maximum 9 probability over all potential ancestors:
Calculation of probability of infection P infect from growth rates 12
To obtain the fitness landscape in Figure 3 , we define the probability of infection of each 13 haplotype as P inf = Θ(ρ-10 -3 ), where ρ is the growth rate of the haplotype calculated as described 14
below. Applying this threshold is motivated by the fact that the distribution of growth rates is 15
bimodal -most haplotypes are either infective to some extent (ρ>=0.1) or not (ρ=0) with less 16 than 1% of growth rates fall within the intermediate region (see 17 Figure 3-figure supplement 1A) . Consequently, the setting of the threshold is insensitive in the 18 region (0,0.1). 19 20 Calculation of growth rates from haplotype frequencies 21
We calculate growth rates by comparing between haplotype frequencies of consecutive 22 generations. To avoid sequencing errors, we only consider frequencies with P-value≤10 -4 . 23
Additionally, since our growth rates are relative to that of the wildtype wt, we only use data from 24 the first 2 passages of evolution, where the wt is still the most abundant haplotype. 25
For each pair of consecutive generations that were sequenced, we calculate the growth rate ρ i of 26 all haplotypes that were detected in the samples using a simple linear model: 27
where n i and n i ' are the copy numbers of haplotype i in the first and second generation 29 respectively. We ignore mutation rates since mutation rates of MNV (~10 -4 ) are smaller than the 30 sequencing errors (~10 -3 ). Assuming unbiased sampling of original copies during sequencing, we 31 substitute: 32
where f i and f i ' are the frequency of haplotype i measured by sequencing the first and the second 3 sample respectively. When we use these substitutions in the original equation (1) we get: 4
the resulting set of linear equations, one per haplotype, is a homogenous system: 7
where the parameter matrix is A ij = f i 'f j -δ ij and the growth rates vector is Ρ j = ρ j . 9
The non-trivial solution solves for all growth rates, assuming a growth rate of 1 for the wild type. 10
Since the same haplotype may exist in more than one pair of consecutive generations, multiple 11 growth rates can be assigned to the same haplotype, in which case the average growth rate is 12 calculated for this haplotype. The distribution of all growth rates is plotted in 13 We assume that the fitness F is proportional to fraction of MNV-1 P-domain that are folded and 17 free from the antibody. If we further assume that the MNV-1 P-domain exists in three states-18 folded unbound, folded bound and unfolded (always unbound)-then we can express fitness F 19 as 20
where ∆G fold and ∆G bind are the free energies of folding and binding, Ab [ ] is the antibody 22 concentration, C 0 is the standard reference concentration and β=1/k B T. The parameter 23 m accounts for the added entropy due to the fact that any of the 180 P-domains on the viral 1 capsid have a similar contribution to the neutralization of the capsid. 2
We note that this formulation takes into account the known experimental fact that binding 3 induces folding. Specifically, the total fraction of folded proteins is the sum of proteins that are 4 folded and bound to the Ab and proteins that are folded and free, and then normalized by total 5 number of proteins in solution: 
That is, when there is a sufficient amount of 9 antibody or when the binding to the Ab is very tight, all P-domains will eventually bind to the 10 antibody and be folded. 11 12 Fitness effects of mutations (selection coefficient) on the viral fitness landscape 13
Conceptually, evolution may be thought of as a hill-climbing process, whereby the rate of ascent 14 is proportional to the effect of mutations on fitness. The fitness effect of a mutation is quantified 15 by the selection coefficient s=(F mut -F wt )/F wt . The subscript "mut" and "wt" refers to mutant and 16 wildtype, respectively. At the protein level, a non-synonymous mutation will change the folding 17 and binding free energies as ∆G From Equation 10, the magnitude of the selection coefficient of a given mutation depends on the 5 wildtype folding stability (∆G fold,wt ) and binding affinity (K d,wt ); hence, there is strong epistasis 6 on the fitness landscape. Moreover, because a single mutation can affect both folding and 7
binding-mutations are pleiotropic in their effect to proteins-both terms in Equation 10 8 contribute to the selection coefficient. This epistasis-pleiotropy link at the level of protein 9
biophysics is the origin of the coupling between the selection for folding stability and binding. 10
The difference in sign for the two terms in Equation 10 also denotes the opposite direction of 11 selection for the two biophysical traits. Along folding stability, selection points towards more 12 stable proteins (more negative values of ∆G fold ); along binding affinity, selection points towards 13 weaker binding (larger values of K d ) (Figure 5A) . By contrast, randomly occurring mutations 14 tend to destabilize proteins and protein-protein complexes 38,39 , rendering both ΔΔG fold and 15
ΔΔG bind more positive. Thus, along folding stability, mutational drift points towards less stable 16
proteins, opposite to the selective force; however, along binding affinity, drift also points 17 towards weaker binding (Figure 5A) , parallel to the selective force. We present a formal 18 treatment of the balance between selection and drift in the next section. 19
Balance between selection and mutational drift on the fitness landscape: Theoretical analysis 20
We now formally combine the contribution of drift and selection and quantitatively determine 21 the course MNV-1 evolution on the fitness landscape. We first limit ourselves to the simple 22 monoclonal regime, where each generation is dominated by just one strain with a probability 23 equal to its probability of fixation. To that end, we compare the probability of fixation of a non-24 synonymous mutation that changes folding stability and binding with the probability of fixation 1 of a synonymous mutation, which we assume is neutral (s=0). We denote this ratio as ω. The 2 underlying motivation for this ratio is that when ω=1, mutations are neutral at the level of fitness, 3 and mutational drift dominates. Specifically, 51 4 where is the probability of fixation 4 , N e is the population size and s is the selection 6 coefficient (Equation 10). s is a function of the wildtype folding stability wt G Δ and binding 7 affinity K 0 and the changes induced by the mutation to folding stability and binding ∆∆G bind and 8 ∆∆G fold . Because the effect of random mutations on folding stability and binding, denoted by 9 p(∆∆G fold ) and p(∆∆G bind ), are well-characterized 38,39 , we can derive the rate of protein evolution 10 averaged over all possible effect of random mutations on folding and binding, that is, 11 Eq. S10 defines the average stringency of Darwinian selection as a function of background, and 13
hence the strength of epistatic interaction on the fitness landscape defined by protein folding and 14 binding. 15
We show in Figure 5A Figure 5A) . The prediction is that if the population starts in the unstable regime, it would 20 migrate away from the regime where selection is strong and towards the regime where it is more 21 neutral. 22
23
Simulations of evolutionary dynamics on the fitness landscape: Monoclonal regime 24
We complement our theoretical analysis above by performing explicit simulation of population 25 dynamics. This evolutionary dynamics allows for the occurrence of random mutation and then 26 selection. The algorithm is as follows: 27
Initialization 28
We start with a viral population of size N. Since the population is monoclonal, the entire 29 population is uniquely determined by single values of folding stability and binding affinity. That 30 P fix s, N e ( ) is, the population is a single point defined by the ordered pair (∆G fold , K d ). For the simulation 1 shown in Figure 5A -B, the population starts at (-2.5 kcal/mol, 46 nM). The analyses in the previous section are performed in the monoclonal regime, where a closed 20 formula of the stringency of selection is tractable. However, a true viral quasi-species is 21 necessarily polyclonal because of the high mutation rate, thus, we also perform forward 22 polyclonal regime simulation, for which the closed form formula for the stringency of selection 23 is no longer accurate. Results are shown in Figure 5-figure supplement 1 . 24
Initialization 25
We start with a viral population of size N. Each of the N virion in the population is characterized 26 by its folding stability and binding affinity. Thus, the entire population constitutes a distribution 27 of ΔG fold and K d values and migrates as a "cloud" on the fitness landscape. For the simulation 28
shown in Fig. S4 , we start with a population of N randomly chosen variants from the sequenced 29 MNV-1 viral stock. 
